Axil Brands, Inc. (AXIL) stock
AXILNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 19/3059% below fair value
$4.94−0.05 (-1.00%)
Close on Nov 17, 2026Market cap $33.70MP/E 14.5Yield –
Axil Brands operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Axil Brands's operating cash flow for the twelve months ending Aug 31, 2026 was $4.49M, up 1437.7% year over year. For fiscal 2026 it was -$9.64K, down 100.5% from the year before. The highest annual figure on record is $2.92M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$9.64K | -100.5% |
| FY2025 | May 31, 2025 | $1.93M | +71945.6% |
| FY2024 | May 31, 2024 | $2.68K | -99.9% |
| FY2023 | May 31, 2023 | $2.92M | – |
| FY2022 | May 31, 2022 | -$126.06K | -360.4% |
| FY2021 | May 31, 2021 | $48.41K | – |
| FY2020 | May 31, 2020 | -$89.70K | – |
| FY2019 | May 31, 2019 | -$175.04K | – |
| FY2018 | May 31, 2018 | -$468.49K | – |
| FY2017 | May 31, 2017 | -$369.97K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $3.76M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$799.97K | -511.4% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $594.72K | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $934.80K | -7.2% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$739.19K | -182.4% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $194.43K | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$169.94K | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $1.01M | +17.8% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $897.32K | +125.9% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$336.65K | -156.3% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$912.79K | -837.4% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $854.94K | -38.4% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $397.17K | -50.8% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $598.16K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $123.78K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $1.39M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $807.63K | +9610.6% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$35.18K | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$62.81K | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$36.38K | -125.5% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $8.32K | -54.2% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$25.81K | -125.2% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$86.85K | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $142.90K | +1676.7% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $18.16K | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $102.27K | – |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$193.89K | -818.5% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $8.04K | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$6.13K | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | -$54.83K | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $26.99K | – |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -$60.57K | – |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$86.63K | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$28.97K | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$87.39K | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$154.01K | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$198.13K | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$134.69K | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | -$81.41K | – |
See a number that looks wrong?